Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Peter Mathen"'
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-6 (2021)
Abstract Glioblastoma is the most common primary brain malignancy and carries with it a poor prognosis. New agents are urgently needed, however nearly all Phase III trials of GBM patients of the past 25 years have failed to demonstrate improvement in
Externí odkaz:
https://doaj.org/article/6874a4b0370247c5a0bcb41841347f81
Autor:
Angela MY. Chan, Gloria Roldan Urgoiti, Will Jiang, Sandra Lee, Elizabeth Kornaga, Peter Mathen, Rosanna Yeung, Emeka K. Enwere, Alan Box, Mie Konno, Martin Koebel, Kurian Joseph, Corinne M. Doll
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundProgrammed death-ligand 1 (PD-L1) expression has been shown to be prognostic in many cancer types and used in consideration of checkpoint inhibitor immunotherapy. However, there are very limited and conflicting data on the prognostic impact
Externí odkaz:
https://doaj.org/article/c4113dee65734a5691f506b596a4b519
Autor:
Robert W. Miller, Ying Zhuge, Andra Krauze, Holly Ning, Peter Mathen, Jason Y. Cheng, Kevin Camphausen
Publikováno v:
Med Phys
Purpose Gliomas are the most common primary tumor of the brain and are classified into grades I-IV of the World Health Organization (WHO), based on their invasively histological appearance. Gliomas grading plays an important role to determine the tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7b545439b6d4be094560f090f1dfe6
https://doi.org/10.1002/mp.14168
https://doi.org/10.1002/mp.14168
Autor:
Veeraj Shah, Kathleen Wall, Christine Siegel, Christine Bryla, Tito R. Mendoza, Elizabeth Vera, Peter Mathen, Nicole Leggiero, Orwa Aboud, Jennifer Reyes, Marta Penas-Prado, Alvina Acquaye, Kevin Camphausen, Ramya Antony, Mark R. Gilbert, Eric Burton, Sonja Crandon, Lindsay Rowe, Jing Wu, Terri Armstrong, Christine Cordova, Yamini Vyas, Lisa Boris
Publikováno v:
Journal of neuro-oncology, vol 147, iss 2
Journal of Neuro-Oncology
Journal of Neuro-Oncology
Purpose Body image (BI) is an important issue for cancer patients, as patients with BI concerns are susceptible to depression, anxiety, difficulty coping, and poor quality of life (QoL). While this concern has been documented in patients with other m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05513d80092a36805a672443143d8168
https://doi.org/10.1007/s11060-020-03433-8
https://doi.org/10.1007/s11060-020-03433-8
Autor:
Ying Zhuge, Holly Ning, Jason Y. Cheng, Erdal Tasci, Peter Mathen, Kevin Camphausen, Robert W. Miller, Andra V. Krauze
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::623ffcb6e46e51fafcd74e0fcc32835e
https://doi.org/10.2139/ssrn.4243554
https://doi.org/10.2139/ssrn.4243554
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-6 (2021)
Radiation Oncology, Vol 16, Iss 1, Pp 1-6 (2021)
Glioblastoma is the most common primary brain malignancy and carries with it a poor prognosis. New agents are urgently needed, however nearly all Phase III trials of GBM patients of the past 25 years have failed to demonstrate improvement in outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac27ab0b6125ee07a0ce769f57e2b93
https://doi.org/10.1186/s13014-021-01918-y
https://doi.org/10.1186/s13014-021-01918-y
Publikováno v:
Biomarkers in Medicine. 13:161-165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a227f7ff72d55db36b744e9aa3dd18
https://doi.org/10.2217/bmm-2018-0463
https://doi.org/10.2217/bmm-2018-0463
Autor:
DeeDee Smart, Peter Mathen
Publikováno v:
Neuro Oncol
BACKGROUND: Pulsed radiation therapy (PRT) has shown effective tumor control and superior normal-tissue sparing ability compared with standard radiotherapy (SRT) in preclinical models and retrospective clinical series. This is the first prospective t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6f3682b22888812db2c3d634d60408
https://doi.org/10.1093/neuonc/noab008
https://doi.org/10.1093/neuonc/noab008
Publikováno v:
Neurooncol Pract
Glioblastoma (GBM) is a challenging diagnosis with almost universally poor prognosis. Though the survival advantage of postoperative radiation (RT) is well established, around 90% of patients will fail in the RT field. The high likelihood of local fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e50239ddc9efb12b5c313782e6aec9
https://europepmc.org/articles/PMC7274183/
https://europepmc.org/articles/PMC7274183/
Autor:
Megan Mackey, Uma Shankavaram, Charlotte Anne Miller, Mary Sproull, Peter Mathen, Kevin Camphausen, DeeDee Smart, Teresa Cooley
Publikováno v:
J Biochem Anal Stud
Purpose Glioblastoma (GBM) is the most common form of brain tumor and has a uniformly poor prognosis. Development of prognostic biomarkers in easily accessible serum samples have the potential to improve the outcomes of patients with GBM through pers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee460cef9210292a375c9be711c9791
https://europepmc.org/articles/PMC8057620/
https://europepmc.org/articles/PMC8057620/